完整後設資料紀錄
DC 欄位語言
dc.contributor.authorMorrell, Thomas E.en_US
dc.contributor.authorRafalska-Metcalf, Ilona U.en_US
dc.contributor.authorYang, Hawen_US
dc.contributor.authorChu, Jhih-Weien_US
dc.date.accessioned2019-04-02T05:58:43Z-
dc.date.available2019-04-02T05:58:43Z-
dc.date.issued2018-11-07en_US
dc.identifier.issn0002-7863en_US
dc.identifier.urihttp://dx.doi.org/10.1021/jacs.8b08070en_US
dc.identifier.urihttp://hdl.handle.net/11536/148443-
dc.description.abstractProtein tyrosine phosphatase B (PtpB) from Mycobacterium tuberculosis (Mtb) extends the bacteria's survival in hosts and hence is a potential target for Mtb-specific drugs. To study how Mtb-specific sequence insertions in PtpB may regulate access to its active site through large-amplitude conformational changes, we performed free-energy calculations using an all-atom explicit solvent model. Corroborated by biochemical assays, the results show that PtpB's active site is controlled via an "either/or" compound conformational gating mechanism, an unexpected discovery that Mtb has evolved to bestow a single enzyme with such intricate logical operations. In addition to providing unprecedented insights for its active-site surroundings, the findings also suggest new ways of inactivating PtpB.en_US
dc.language.isoen_USen_US
dc.titleCompound Molecular Logic in Accessing the Active Site of Mycobacterium tuberculosis Protein Tyrosine Phosphatase Ben_US
dc.typeArticleen_US
dc.identifier.doi10.1021/jacs.8b08070en_US
dc.identifier.journalJOURNAL OF THE AMERICAN CHEMICAL SOCIETYen_US
dc.citation.volume140en_US
dc.citation.spage14747en_US
dc.citation.epage14752en_US
dc.contributor.department生物資訊及系統生物研究所zh_TW
dc.contributor.department分子醫學與生物工程研究所zh_TW
dc.contributor.departmentInstitude of Bioinformatics and Systems Biologyen_US
dc.contributor.departmentInstitute of Molecular Medicine and Bioengineeringen_US
dc.identifier.wosnumberWOS:000449887800034en_US
dc.citation.woscount0en_US
顯示於類別:期刊論文